Account wins from the 04/28/06 News Brief

Share this article:
The Navicor Group, an inVentiv Health company and a full-service advertising agency that focuses exclusively on the areas of oncology and immunology, has been named agency of record for Hepsera (adefovir dipivoxil), an orally administered prescription medicine for the treatment of chronic hepatitis B. Hepsera was developed by Gilead Sciences. The drug was approved by the FDA in September 2002. The Navicor Group’s assignment includes the development of strategic and creative marketing communications for the product.
Share this article:
You must be a registered member of MMM to post a comment.

This compelling e-book shares a wealth of insights designed to help members of sales forces connect with elusive HCPs. An expanded version has also been created that includes video interviews and other multimedia content. Click here for access.